Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.

Visceral Leishmaniasis and HIV-AIDS coinfection (VL/HIV) is considered a life-threatening pathology when undiagnosed and untreated, due to the immunosuppression caused by both diseases. Serological tests largely used for the VL diagnosis include the direct agglutination test (DAT), ELISA and immunoc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rhaíssa E M Ramos, Wagner J T Santos, Franklin B Magalhães, George T N Diniz, Carlos H N Costa, Osvaldo P de Melo Neto, Zulma M Medeiros, Christian R S Reis
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/65d9654ea7dd4c50a35bc4baeafc4d59
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:65d9654ea7dd4c50a35bc4baeafc4d59
record_format dspace
spelling oai:doaj.org-article:65d9654ea7dd4c50a35bc4baeafc4d592021-11-25T06:19:10ZAssessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.1932-620310.1371/journal.pone.0251861https://doaj.org/article/65d9654ea7dd4c50a35bc4baeafc4d592021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0251861https://doaj.org/toc/1932-6203Visceral Leishmaniasis and HIV-AIDS coinfection (VL/HIV) is considered a life-threatening pathology when undiagnosed and untreated, due to the immunosuppression caused by both diseases. Serological tests largely used for the VL diagnosis include the direct agglutination test (DAT), ELISA and immunochromatographic (ICT) assays. For VL diagnosis in HIV infections, different studies have shown that the use of the DAT assay facilitates the VL diagnosis in co-infected patients, since the performance of the most widely used ELISA and ICT tests, based on the recombinant protein rK39, are much less efficient in HIV co-infections. In this scenario, alternative recombinant antigens may help the development of new serological diagnostic methods which may improve the VL diagnosis for the co-infection cases. This work aimed to evaluate the use of the recombinant Lci2 antigen, related to, but antigenically more diverse than rK39, for VL diagnosis in co-infected sera through ELISA assays. A direct comparison between recombinant Lci2 and rK39 was thus carried out. The two proteins were first tested using indirect ELISA with sera from VL afflicted individuals and healthy controls, with similar performances. They were then tested with two different sets of VL/HIV co-infected cases and a significant drop in performance, for one of these groups, was observed for rK39 (32% sensitivity), but not for Lci2 (98% sensitivity). In fact, an almost perfect agreement (Kappa: 0.93) between the Lci2 ELISA and DAT was observed for the coinfected VL/HIV patients. Lci2 then has the potential to be used as a new tool for the VL diagnosis of VL/HIV co-infections.Rhaíssa E M RamosWagner J T SantosFranklin B MagalhãesGeorge T N DinizCarlos H N CostaOsvaldo P de Melo NetoZulma M MedeirosChristian R S ReisPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 5, p e0251861 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rhaíssa E M Ramos
Wagner J T Santos
Franklin B Magalhães
George T N Diniz
Carlos H N Costa
Osvaldo P de Melo Neto
Zulma M Medeiros
Christian R S Reis
Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.
description Visceral Leishmaniasis and HIV-AIDS coinfection (VL/HIV) is considered a life-threatening pathology when undiagnosed and untreated, due to the immunosuppression caused by both diseases. Serological tests largely used for the VL diagnosis include the direct agglutination test (DAT), ELISA and immunochromatographic (ICT) assays. For VL diagnosis in HIV infections, different studies have shown that the use of the DAT assay facilitates the VL diagnosis in co-infected patients, since the performance of the most widely used ELISA and ICT tests, based on the recombinant protein rK39, are much less efficient in HIV co-infections. In this scenario, alternative recombinant antigens may help the development of new serological diagnostic methods which may improve the VL diagnosis for the co-infection cases. This work aimed to evaluate the use of the recombinant Lci2 antigen, related to, but antigenically more diverse than rK39, for VL diagnosis in co-infected sera through ELISA assays. A direct comparison between recombinant Lci2 and rK39 was thus carried out. The two proteins were first tested using indirect ELISA with sera from VL afflicted individuals and healthy controls, with similar performances. They were then tested with two different sets of VL/HIV co-infected cases and a significant drop in performance, for one of these groups, was observed for rK39 (32% sensitivity), but not for Lci2 (98% sensitivity). In fact, an almost perfect agreement (Kappa: 0.93) between the Lci2 ELISA and DAT was observed for the coinfected VL/HIV patients. Lci2 then has the potential to be used as a new tool for the VL diagnosis of VL/HIV co-infections.
format article
author Rhaíssa E M Ramos
Wagner J T Santos
Franklin B Magalhães
George T N Diniz
Carlos H N Costa
Osvaldo P de Melo Neto
Zulma M Medeiros
Christian R S Reis
author_facet Rhaíssa E M Ramos
Wagner J T Santos
Franklin B Magalhães
George T N Diniz
Carlos H N Costa
Osvaldo P de Melo Neto
Zulma M Medeiros
Christian R S Reis
author_sort Rhaíssa E M Ramos
title Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.
title_short Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.
title_full Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.
title_fullStr Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.
title_full_unstemmed Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.
title_sort assessment of a recombinant protein from leishmania infantum as a novel tool for visceral leishmaniasis (vl) diagnosis in vl/hiv co-infection cases.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/65d9654ea7dd4c50a35bc4baeafc4d59
work_keys_str_mv AT rhaissaemramos assessmentofarecombinantproteinfromleishmaniainfantumasanoveltoolforvisceralleishmaniasisvldiagnosisinvlhivcoinfectioncases
AT wagnerjtsantos assessmentofarecombinantproteinfromleishmaniainfantumasanoveltoolforvisceralleishmaniasisvldiagnosisinvlhivcoinfectioncases
AT franklinbmagalhaes assessmentofarecombinantproteinfromleishmaniainfantumasanoveltoolforvisceralleishmaniasisvldiagnosisinvlhivcoinfectioncases
AT georgetndiniz assessmentofarecombinantproteinfromleishmaniainfantumasanoveltoolforvisceralleishmaniasisvldiagnosisinvlhivcoinfectioncases
AT carloshncosta assessmentofarecombinantproteinfromleishmaniainfantumasanoveltoolforvisceralleishmaniasisvldiagnosisinvlhivcoinfectioncases
AT osvaldopdemeloneto assessmentofarecombinantproteinfromleishmaniainfantumasanoveltoolforvisceralleishmaniasisvldiagnosisinvlhivcoinfectioncases
AT zulmammedeiros assessmentofarecombinantproteinfromleishmaniainfantumasanoveltoolforvisceralleishmaniasisvldiagnosisinvlhivcoinfectioncases
AT christianrsreis assessmentofarecombinantproteinfromleishmaniainfantumasanoveltoolforvisceralleishmaniasisvldiagnosisinvlhivcoinfectioncases
_version_ 1718413928456781824